Refine by
Patient Access Articles & Analysis: This-Year
1 articles found
Overall screening rates more than doubled, from 45% to 90%, illustrating the value of accessible blood tests in boosting uptake.Commitment to Broader AccessMotivated by Shield’s impact to date, the company is continuing to invest in technology, expand teams, and deepen partnerships to bring Shield to more people, families, and communities worldwide.During Colorectal Cancer ...